Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ditte-Marie Bretler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 20, 2013
Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trialsHelena W Rodbard, Stephen Gough, Wendy Lane, et al.
Ugeskrift for Laeger|January 9, 2009
[Peripartum cardiomyopathy]Ditte-Marie Bretler, Casper Haslund Jørgensen, Jonas Bjerring Olesen, et al.
Diabetes Care|May 10, 2017
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 TrialKeith Bowering, Christopher Case, John Harvey, et al.
Plos One|January 4, 2013
Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort studyDitte-Marie Bretler, Peter Riis Hansen, Jesper Lindhardsen, et al.
BMJ (Clinical Research Ed.)|March 29, 2012
Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort studyDitte-Marie Bretler, Peter Riis Hansen, Rikke Sørensen, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2013
Risk factors for venous thromboembolism during pregnancyThomas Bo Jensen, Thomas Alexander Gerds, Randi Grøn, et al.
British Journal of Clinical Pharmacology|December 15, 2010
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide studyDitte-Marie Bretler, Peter Riis Hansen, Steen Zabell Abildstrøm, et al.
Plos One|April 6, 2011
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyOle Ahlehoff, Gunnar Hilmar Gislason, Jesper Lindhardsen, et al.
Journal of the American College of Cardiology|March 27, 2010
Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide studyLisbeth Bonde, Rikke Sorensen, Emil Loldrup Fosbøl, et al.
European Heart Journal|December 27, 2011
Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillationJakob Raunsø, Christian Selmer, Jonas Bjerring Olesen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 20, 2013
Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trialsHelena W Rodbard, Stephen Gough, Wendy Lane, et al.
Ugeskrift for Laeger|January 9, 2009
[Peripartum cardiomyopathy]Ditte-Marie Bretler, Casper Haslund Jørgensen, Jonas Bjerring Olesen, et al.
Diabetes Care|May 10, 2017
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 TrialKeith Bowering, Christopher Case, John Harvey, et al.
Plos One|January 4, 2013
Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort studyDitte-Marie Bretler, Peter Riis Hansen, Jesper Lindhardsen, et al.
BMJ (Clinical Research Ed.)|March 29, 2012
Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort studyDitte-Marie Bretler, Peter Riis Hansen, Rikke Sørensen, et al.
Pharmacoepidemiology and Drug Safety|October 17, 2013
Risk factors for venous thromboembolism during pregnancyThomas Bo Jensen, Thomas Alexander Gerds, Randi Grøn, et al.
British Journal of Clinical Pharmacology|December 15, 2010
Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide studyDitte-Marie Bretler, Peter Riis Hansen, Steen Zabell Abildstrøm, et al.
Plos One|April 6, 2011
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort studyOle Ahlehoff, Gunnar Hilmar Gislason, Jesper Lindhardsen, et al.
Journal of the American College of Cardiology|March 27, 2010
Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide studyLisbeth Bonde, Rikke Sorensen, Emil Loldrup Fosbøl, et al.
European Heart Journal|December 27, 2011
Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillationJakob Raunsø, Christian Selmer, Jonas Bjerring Olesen, et al.
Pageof 2